3//SEC Filing
GV 2017 GP, L.L.C. 3
Accession 0000899243-18-007414
CIK 0001724521other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:42 PM ET
Size
21.4 KB
Accession
0000899243-18-007414
Insider Transaction Report
Form 3
GV 2017 GP, L.P.
10% Owner
Holdings
- (indirect: By GV 2017, L.P.)
Series C Convertible Preferred Stock
→ Common Stock (1,924,474 underlying)
GV 2017, L.P.
10% Owner
Holdings
- (indirect: By GV 2017, L.P.)
Series C Convertible Preferred Stock
→ Common Stock (1,924,474 underlying)
GV 2017 GP, L.L.C.
10% Owner
Holdings
- (indirect: By GV 2017, L.P.)
Series C Convertible Preferred Stock
→ Common Stock (1,924,474 underlying)
Alphabet Inc.
10% Owner
Holdings
- (indirect: By GV 2017, L.P.)
Series C Convertible Preferred Stock
→ Common Stock (1,924,474 underlying)
Footnotes (2)
- [F1]The reported security is directly held by GV 2017, L.P. GV 2017 GP, L.P., the general partner of GV 2017, L.P., GV 2017 GP, L.L.C., the general partner of GV 2017 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2017 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2017 GP, L.P., GV 2017 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- [F2]The reported security is convertible into the Issuer's Common Stock on a 1-for-1 basis at any time at the holder's election and shall automatically convert into Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001733338
Filing Metadata
- Form type
- 3
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:42 PM ET
- Size
- 21.4 KB